DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Nov 27, 2013
Insider Transaction Report
Form 4
Garner William J
Director
Transactions
- Conversion
Warrants (Right to Buy)
2013-11-26−5,000→ 45,000 total(indirect: By LLC)Exercise: $1.20From: 2011-10-03Exp: 2014-01-25→ Common Stock (5,000 underlying) - Conversion
Common Stock
2013-11-26+5,000→ 10,000 total(indirect: See Footnote)
Footnotes (2)
- [F1]Warrants were exercised for no additional consideration. The exercise price of the remaining warrants is $1.20.
- [F2]5,000 shares are held directly and 5,000 shares are held by EGB Advisors, LLC, which is owned by Mr. Garner.